CGEN Stock Analysis: Buy, Sell, or Hold?

CGEN - Compugen Ltd

Biological Products, (No Diagnostic Substances)
$2.38
0.03 (1.28%) β–²
5d: +0.0%
30d: +4.39%
90d: -12.18%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 03, 2026 0d

Get Alerted When CGEN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ’‘ BUY OPPORTUNITY: CGEN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
See Forward Earnings Fair Value & Price Prediction β†’

In-depth Analysis How we analyze

Valuation Analysis: CGEN is currently trading at $2.38, which is considered slightly high relative to its 30-day fair value range of $2.20 to $2.42.

Technical Outlook: Technically, CGEN is showing sideways momentum. Immediate support is located at $2.17, while resistance sits at $2.52.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (11th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $4.60 (+95.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $2.20 - $2.42
Company Quality Score 52/100 (HOLD)
Options IV Signal 11th percentile (LOW)
Volume Confirmation HIGH
Confidence Score 73.8%

All Signals

  • BULLISH: Options cheap (IV 11th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 95.7% below Wall St target ($4.60)

Trading Range Analysis

30-Day Trading Range $2.20 - $2.42
Current vs Trading Range SLIGHTLY HIGH
Expected Move (7 Days) Β±$0.22 (9.4%)

Support & Resistance Levels

Support Level $2.17
Resistance Level $2.52
Current Trend Sideways
Technical data as of Aug 3, 2026

Fundamental Context

Forward P/E (Next Year Est.) -6.44
Wall Street Target $4.60 (+95.7%)
Revenue Growth (YoY) -4.7%
Profit Margin 48.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 03, 2026 3:53 PM ET
Data refreshes hourly during market hours. Next update: 4:53 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Eran Ophir SELL 5000 shares 2026-04-14
Zurit Levine SELL 3125 shares 2026-04-10
Zurit Levine SELL 5375 shares 2026-04-08

Unlock Insider Activity

See real-time buying/selling by company executives for CGEN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
DNLI
Denali Therapeutics Inc
STRONG BUY
19 analysts
$34 55 HOLD
INCY
Incyte Corporation
HOLD
27 analysts
$123 59 HOLD
RNA
Atrium Therapeutics, Inc…
STRONG BUY
15 analysts
$25 54 HOLD
IRON
Disc Medicine Inc.
STRONG BUY
11 analysts
$102 60 HOLD
ARWR
Arrowhead Pharmaceutical…
STRONG BUY
13 analysts
$108 60 BUY

More Analysis for CGEN

CGEN Technical Chart CGEN Price Prediction CGEN Earnings Date CGEN Investment Advisor CGEN Fair Price Analyzer CGEN Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals